NIO Inc. Announces Proposed Offering of 60,000,000 American Depositary Shares

Written by Customer Service on June 9, 2020. Posted in Public Companies.

SHANGHAI, China, June 09, 2020 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO) (“NIO” or the “Company”), a pioneer in China’s premium smart electric vehicle market, today announced the commencement of the offering of 60,000,000 American depositary shares (the “ADSs”), each representing one Class A ordinary share of the Company (the “ADS Offering”). The Company intends to grant the underwriters in the ADS Offering a 30-day option to purchase up to an additional 9,000,000 ADSs.Morgan Stanley & Co. LLC, Credit Suisse Securities (USA) LLC and China International Capital Corporation Hong Kong Securities Limited are acting as the joint book-running managers for the ADS Offering.The ADSs will be offered under the Company’s shelf registration statement on Form F-3 which was filed with the Securities and Exchange Commission (the “SEC”) and automatically...

MVC Capital Announces Second Quarter 2020 Results

Written by Customer Service on June 9, 2020. Posted in Public Companies.

PURCHASE, N.Y., June 09, 2020 (GLOBE NEWSWIRE) — MVC Capital, Inc. (NYSE: MVC) (the “Company”), a publicly traded business development company (BDC) that makes private debt and equity investments, announced its financial results for the fiscal second quarter ended April 30, 2020.Financial ResultsFor the second quarter of fiscal 2020, the Company earned interest income of $7.5 million and dividend, fee and other income of $0.2 million, compared to $6.4 million and $2.2 million, respectively, for the same quarter of fiscal 2019.The Company reported total operating income of $7.7 million for the second quarter of fiscal 2020, compared to $8.6 million for the second quarter of fiscal 2019. The Company reported net operating income of $3.5 million for the second quarter of fiscal 2020, compared to $4.2 million for the same quarter in...

Northland Power Renews Preliminary Base Shelf Prospectus

Written by Customer Service on June 9, 2020. Posted in Public Companies.

Not for distribution to U.S. newswire services or for dissemination in the United States or its possessions. Any failure to comply with this restriction may constitute a violation of U.S. securities law.TORONTO, June 09, 2020 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today filed a preliminary short form base shelf prospectus with the securities regulatory authorities in each of the provinces of Canada. This filing, when made final, will replace Northland’s expiring base shelf prospectus dated May 24, 2018 and will enable Northland to offer an aggregate of up to $1 billion of common shares, preferred shares, warrants, unsecured debentures, subscription receipts and units or any combination thereof, over a 25-month period.Northland has no immediate intent to issue...

SiTime Corporation Announces Launch of Follow-on Public Offering

Written by Customer Service on June 9, 2020. Posted in Public Companies.

SANTA CLARA, Calif., June 09, 2020 (GLOBE NEWSWIRE) — SiTime Corporation (Nasdaq: SITM), a market leader in MEMS timing, announced today it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission related to a proposed follow-on public offering of 3,500,000 shares of its common stock, including 2,500,000 shares of common stock to be sold by MegaChips Corporation and 1,000,000 shares to be issued and sold by SiTime. In addition, SiTime intends to grant the underwriters a 30-day option to purchase up to 525,000 additional shares of common stock from SiTime. SiTime will not receive any proceeds from the sale of shares of common stock by MegaChips Corporation. Net proceeds to SiTime are expected to be used for repayment of debt and general corporate purposes.Barclays and Stifel are joint...

CareDx Announces Proposed Public Offering of Common Stock

Written by Customer Service on June 9, 2020. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., June 09, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that it intends to offer and sell, subject to market and other conditions, up to $100.0 million of shares of its common stock in an underwritten public offering. CareDx also expects to grant the underwriters of the offering a 30-day option to purchase up to an additional $15.0 million of shares of its common stock offered in the public offering on the same terms and conditions. All of the shares will be offered and sold by CareDx.CareDx intends to use the net proceeds from this offering for working capital and general corporate...

SANUWAVE Health to Hold Investor Live Webcast on Wednesday, June 10, 2020

Written by Customer Service on June 9, 2020. Posted in Public Companies.

SUWANEE, GA, June 09, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a live webcast and conference call on Wednesday, June 10, 2020, beginning at 9AM Eastern Time to provide a business update. Shareholders and other interested parties can participate in the live webcast at https://www.webcaster4.com/Webcast/Page/2249/35268.Shareholders and other interested parties can also participate in the conference call by dialing 844-602-0380 (U.S.) or 862-298-0970 (international). Please join the call at least 10 minutes before the start time.A replay of the webcast and conference call will be available beginning two hours after its completion through June 17, 2020, by dialing 877-481-4010 (U.S.) or 919-882-2331 and entering replay passcode 35268 and a replay...

Angus Ventures Announces Flow-Through Private Placement

Written by Customer Service on June 9, 2020. Posted in Public Companies.

TORONTO, June 09, 2020 (GLOBE NEWSWIRE) — Angus Ventures Inc. (TSX-V: GUS) (“Angus” or the “Company”) is pleased to announce a non-brokered private placement up to 6,000,000 flow-through common shares (the “FT Common Shares”) of the Company at a price of $0.441 per FT Common Share for gross proceeds of up to $2,646,000 (the “Financing”).The gross proceeds from the Financing will be used to fund Canadian Exploration Expenses (within the meaning of the Income Tax Act (Canada)) which shall qualify as “flow-through mining expenditures”, for purposes of the Income Tax Act (Canada), related to the Company’s Golden Sky Project in Wawa, Ontario.The closing of the Financing is expected to occur on or about June 30, 2020 and is subject to the receipt of regulatory approvals, including the approval of the TSX Venture Exchange...

ERYTECH aktualisiert Informationen zur prüfarztgesponserten Phase-II-Studie von Eryaspase als Zweitlinientherapie bei akuter lymphoblastischer Leukämie

Written by Customer Service on June 9, 2020. Posted in Public Companies.

Patientenrekrutierung ist abgeschlossen; 50 Patienten nehmen an der Studie teilErmutigende vorläufige Ergebnisse auf der Basis von InterimsdatenUngedeckter medizinischer Bedarf von der FDA bestätigtLYON, Frankreich und CAMBRIDGE, Massachusetts, USA, June 09, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das innovative Therapien entwickelt, bei denen Arzneimittelwirkstoffe in roten Blutkörperchen eingekapselt werden, hat heute aktuelle Informationen zu der von der Nordic Society of Paediatric Haematology and Oncology (NOPHO) gesponserten laufenden Phase-II-Studie von Eryaspase als Zweitlinientherapie bei Patienten mit akuter lymphoblastischer Leukämie (ALL) bekanntgegeben.Die NOR-GRASPALL-2016-Studie untersucht die Sicherheit und Wirksamkeit...

ERYTECH fornisce un aggiornamento sullo studio di fase 2 sponsorizzato dallo sperimentatore di Eryaspase per il trattamento di seconda linea della leucemia linfoblastica acuta

Written by Customer Service on June 9, 2020. Posted in Public Companies.

Arruolamento dei pazienti completato; 50 pazienti nello studioRisultati preliminari sulla base di dati intermedi incoraggiantiNecessità medica non soddisfatta confermata dalla FDALIONE, Francia e CAMBRIDGE, Mass., June 09, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), un’azienda biofarmaceutica in fase clinica che sviluppa terapie innovative incapsulando sostanze terapeutiche all’interno dei globuli rossi, oggi ha fornito un aggiornamento sullo studio di fase 2 in corso, sponsorizzato dalla Nordic Society of Pediatric Haematology and Oncology (NOPHO) sull’utilizzo di eryaspase per il trattamento di seconda linea di pazienti affetti da leucemia linfoblastica acuta (LLA).Lo studio NOR-GRASPALL-2016 valuta la sicurezza e l’attività di eryaspase in pazienti prevalentemente pediatrici affetti da leucemia linfoblastica...

CORRECTION – Bombardier Announces Virtual Annual Meeting of Shareholders

Written by Customer Service on June 9, 2020. Posted in Public Companies.

Date and time added:MONTREAL, June 09, 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) announced today that it will host its 2020 Annual Meeting of Shareholders (“Meeting”) on June 18, 2020 at 10:30 EDT in a virtual format due to the ongoing public health concerns related to the COVID-19 pandemic. The Corporation previously announced in its 2020 Notice of Meeting that, subject to public health conditions and concerns, it would host a hybrid Meeting format, whereby registered shareholders and duly appointed proxyholders could attend and participate either in person or via a live webcast. However, given the continued risks associated with hosting gatherings during the COVID-19 pandemic, the Company has made the decisions to adopt a pure virtual format with no in-person participation.Bombardier therefore welcomes all registered shareholders...

Day: June 9, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice